<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref6">
 <mixed-citation publication-type="journal" id="cit6">
  <name>
   <surname>Bort</surname>
   <given-names>G.</given-names>
  </name>; 
  <name>
   <surname>Lux</surname>
   <given-names>F.</given-names>
  </name>; 
  <name>
   <surname>Dufort</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Crémillieux</surname>
   <given-names>Y.</given-names>
  </name>; 
  <name>
   <surname>Verry</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Tillement</surname>
   <given-names>O.</given-names>
  </name>
  <article-title>EPR-Mediated Tumor Targeting Using Ultrasmall-Hybrid Nanoparticles: From Animal to Human with Theranostic AGuIX Nanoparticles</article-title>. 
  <source>Theranostics</source>
  <year>2020</year>, 
  <volume>10</volume>, 
  <fpage>1319</fpage>–
  <lpage>1331</lpage>. 
  <pub-id pub-id-type="doi">10.7150/thno.37543</pub-id>.
  <pub-id pub-id-type="pmid">31938067</pub-id>
 </mixed-citation>
</ref>
